Episode Details

Back to Episodes
Improving a Drug for Managing Schizophrenia…Heather Turner, CEO, LB Pharmaceuticals

Improving a Drug for Managing Schizophrenia…Heather Turner, CEO, LB Pharmaceuticals

Episode 26039 Published 1 month, 1 week ago
Description

This week on Biotech Nation, Heather Turner of LB Pharmaceuticals joins to discuss a drug that’s new to the US, but not-so-new to Europe, where it’s already been in use for a couple of years. Intended for managing neuropsychiatric conditions like Schizophrenia, the drug is taken by several million people, but the approval process in the US has had to start back at square one. We look at why that is, and how LB is working on it. 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us